Navigation Links
Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
Date:7/1/2008

treatment can reduce the hair count by 10%-40%, thus the results position Applisonix' technology within the highest level of hair removal technologies.

Prof. Yitzhak Peterburg, Applisonix' chairman, stated that this breakthrough paves the road for Applisonix to join the leading aesthetic companies in the world in the hair removal market. "Applisonix", added Peterburg "presents a combination of an innovative, exciting technology, a huge potential market, and impressive execution capabilities."

For further information please contact:

Israel: USA:

Alon Goren - Co-CEO Yossi Aloni - VP Marketing and Business

Uri Amir - Co-CEO Development

+972(8)936-3604 +1-858-427-5279


'/>"/>
SOURCE Applisonix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
3. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
4. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
6. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
7. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
8. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
9. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
10. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
11. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Expressing Growing Concern THCA Urges Texas Congressional Delegation to Protect Seniors Medicare Funded Nursing Home Care as Health Reform Debate Pro 52596 1Expressing Growing Concern THCA Urges Texas Congressional Delegation to Protect Seniors Medicare Funded Nursing Home Care as Health Reform Debate Pro 52596 2Jury Awards Valley Medical Center Patient 241 8 Million for Nursing Negligence 52592 1Jury Awards Valley Medical Center Patient 241 8 Million for Nursing Negligence 52592 2Jury Awards Valley Medical Center Patient 241 8 Million for Nursing Negligence 52592 3Bone from blood 3A Circulating cells form bone outside the normal skeleton Penn study finds 52588 1Bone from blood 3A Circulating cells form bone outside the normal skeleton Penn study finds 52588 2